# Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study

> **NCT03057158** · — · COMPLETED · sponsor: **Duke University** · enrollment: 257 (actual)

## Conditions studied

- Overactive Bladder
- Insulin Resistance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03057158
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2020-03-09
- **Final completion:** 2020-03-11
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2020-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03057158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03057158, "Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03057158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*